TIMP2 reverses inflammatory aging of brain microglia

TIMP2, a protein abundant in young plasma, reverses maladaptive changes that microglia—the brain's immune cells—undergo during aging. Researchers demonstrated that TIMP2 absence in mice exacerbates hallmark features of neurological aging: elevated inflammation, impaired debris clearance, and transcriptomic shifts associated with aberrant cell activation. When TIMP2 was administered to aged mice, results were concrete: microglial activation decreased, proportions of pro-inflammatory cells fell, and phagocytosis of physiological substrates improved. The mechanism operates through the extracellular matrix, where TIMP2 regulates synaptic plasticity and consequently normalizes maladapted immune behavior. For longevity-focused readers seeking grounded interventions, this finding suggests that restoring youth-associated protein levels in the brain's cellular niche is not speculation but a viable therapeutic vector against neuroinflammation.